Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Atorvastatin 40 mg daily for 12 months reduces cardiovascular events in lymphoma patients treated with anthracyclines.
Read Full NewsTake 5 minutes to catch up on NeurologyLive®'s highlights from the week ending December 5, 2025.
Following stiripentol’s market authorization in Japan in November 2012, a postmarketing surveillance study was conducted in all patients with Dravet syndrome who initiated treatment.
A study reveals EEG and MRI biomarkers in MOGAD patients with epilepsy, highlighting potential early indicators for refractory epilepsy and improved treatment outcomes.
Despite the availability of antiseizure medications approved for Dravet syndrome, a recent survey presented at AES 2025 showed that these therapies remain underutilized in patients.
Serum Albumin Levels Can Predict Increased Cancer Risk in Hemodialysis
1.
Universal screening approach achieves a comparable detection rate of lung cancer
2.
Living in a more pedestrian-friendly area may reduce the risk of cancer and obesity-related diseases.
3.
Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.
4.
Researchers use AI to monitor side effects of chemotherapy and support families dealing with pediatric cancer.
5.
Loneliness and social isolation linked to heightened risk of death in those with cancer
1.
Understanding Iron Saturation Levels in Your Blood
2.
The Different Types of Cysts and Why They Occur: Insights from a Dermatologist
3.
Evolution of Cancer Care Through Developmental Therapeutics
4.
The Basics of Langerhans Cell Histiocytosis: Understanding a Rare Disease
5.
Exploring the Impact of Adrenal Myelolipoma on the Human Body
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
2.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
3.
Efficient Management of First line ALK-rearranged NSCLC - Part II
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge